Target & Activity
| Target | Activity | Value |
|---|---|---|
| SMYD2 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| BC | IC50 | 1.5 μM | Antitumor activity against human BC cells assessed as inhibition of cell proliferation incubated for 3 to 7 days by CellTiter-Glo assay | [PMID: 35914250] |
| KYSE-150 cell line | IC50 | 1.5 μM | Antitumor activity against human KYSE-150 cells assessed as inhibition of cell proliferation incubated for 3 to 7 days by CellTiter-Glo assay | [PMID: 35914250] |
| KYSE-270 | IC50 | 1.5 μM | Antitumor activity against human KYSE-270 cells assessed as inhibition of cell proliferation incubated for 3 to 7 days by CellTiter-Glo assay | [PMID: 35914250] |
| U2OS | IC50 | 600 nM | Inhibition of SMYD2 (unknown origin) expressed in human U2OS cells assessed as reduction in p53 methylation by Western blot analysis | [PMID: 27075367] |